Combining the results from both mouse and human samples mentioned above, we hypothesized that ADGRG1+CD8+ T cells in the BM of AML patients with RUNX1::RUNX1T1 represent tumor-antigen-experienced cytotoxic T cells. Here, CD8A is linked to acute myeloid leukemia.